Skip to main content
. 2015 Jan 28;21(4):1292–1298. doi: 10.3748/wjg.v21.i4.1292

Figure 1.

Figure 1

Probability of bleeding recurrence during the follow-up period (n = 132). A: Incidence of rebleeding with a mean follow-up period of 15 mo; B: Probability of rebleeding was significantly higher in the [non-steroidal antiinflammatory drug (NSAID) group than in the non-NSAID group (P < 0.01)]; C: Probability of rebleeding was significantly higher in the hemodialysis group than in the non-hemodialysis group (P < 0.01).